Selvita

    OverviewSuggest Edit

    Selvita is a drug discovery company serving the pharmaceutical and biotechnology industries. It offers solutions supporting customers and projects within the areas of drug discovery, regulatory studies, as well as research and development.
    TypePublic
    Founded2007
    HQKraków, PL
    Websiteselvita.com
    Employee Ratings3.4

    Latest Updates

    Employees (est.) (Feb 2020)452
    Cybersecurity ratingBMore

    Key People/Management at Selvita

    Miłosz Gruca

    Miłosz Gruca

    Executive Vice President, Director of Biology Department
    Mirosława Zydroń

    Mirosława Zydroń

    Member of the Management Board, Director of Chemistry Department
    Dawid Radziszewski

    Dawid Radziszewski

    Member of the Management Board, General Counsel
    Dariusz Kurdas

    Dariusz Kurdas

    Member of the Management Board, Financial Director
    Tadeusz Wesołowski

    Tadeusz Wesołowski

    Vice Chairman of the Supervisory Board
    Bogusław Sieczkowski

    Bogusław Sieczkowski

    Chief Executive Officer
    Show more

    Selvita Office Locations

    Selvita has offices in Kraków, Poznań, Boston, South San Francisco and in 1 other location
    Kraków, PL (HQ)
    Michała Bobrzyńskiego 14
    Poznań, PL
    Uniwersytetu Poznańskiego 10
    Cambridge, GB
    9 Hills Rd
    Boston, MA, US
    100 Cambridge St Suite 1400
    South San Francisco, CA, US
    Building 83, 611 Gateway Blvd #120
    Show all (5)

    Selvita Online and Social Media Presence

    Embed Graph

    Selvita News and Updates

    Selvita appoints Dean Bornilla as Vice President of Sales, Head of North America

    KRAKOW, Poland, July 19, 2021 /PRNewswire/ -- Selvita, one of the largest preclinical contract research organizations in Europe, announced today the appointment of Dean Bornilla, to the role of Vice President of Sales, Head of North America. Mr. Bornilla will be responsible for a wide...

    Selvita reports strong financial results for H1 2020 and a record backlog

    KRAKOW, Poland, Sept. 10, 2020 /PRNewswire/ -- Selvita (WSE: SLV), one of the largest preclinical contract research organizations in Europe, reported today its H1 2020 financial results and provided a corporate update. For the H1 2020, Selvita reports consolidated revenues of EUR 15.2...

    Selvita Reports Financial Results for Q1 2020: Dynamic Increase in Backlog for 2020 and Strong Position on the Market

    KRAKOW, Poland, May 26, 2020 /PRNewswire/ -- Selvita (WSE: SLV), one of the largest preclinical contract research organizations in Europe, reported today its first quarter 2020 financial results and provided a corporate update. The company continues its dynamic growth and reports backlog...

    Selvita 2019 Financial Results: Accelerated Growth, 43 Percent Increase in Commercial Revenues and a Very Solid Backlog for 2020

    KRAKOW, Poland, March 26, 2020 /PRNewswire/ -- Selvita S.A. (WSE: SLV) – one of the largest preclinical contract research organizations in Europe – reported today its annual financial results for 2019 and provided a corporate update. The total commercial revenues of the services segment...

    Selvita Blogs

    Conclusion of a significant purchase order

    The Management Board of Selvita S.A. with its registered office in Krakow (“Selvita”) hereby announces that the company affiliated with Selvita – Fidelta d.o.o. (“Fidelta”) with its registered office in Zagreb, Croatia has concluded on 22th July 2021 a purchase order under a framework agreement exec…

    Notifications from persons discharging managerial responsibilities in the Company – Article 19 of MAR

    The Management Board of Selvita S.A. with its registered office in Krakow (“Company”) hereby informs that the Company received notifications prepared in accordance with Article 19.1 of MAR due to execution of the Stock Grant Program in the Company, about which the Company informed in the current rep…

    Selvita scales its operations with the construction of new research space

    Krakow, Poland – July 12, 2021 – Selvita (WSE: SLV) – one of the largest preclinical contract research organizations in Europe, announced today the initiation of the construction of its own research centre in Krakow. The Company signed an agreement with the General Contractor – PORR S.A., which will…

    Conclusion of the agreement and commencement of the investment for the construction of Selvita Research Center

    The Management Board of Selvita S.A. with its registered office in Krakow (“Company”) with reference to the current report No. 30/2020 of August 31, 2020, the current report No. 38/2020 of December 16, 2020, the current report No. 40/2020 of December 21, 2020 and the current report No. 6/2021 of Apr…

    Information on the change in the shareholder structure due to execution of the Stock Grant Program in the Company – Art. 69 of the Act on Offerings

    The Management Board of Selvita S.A. with its registered office in Krakow (“Company”) hereby informs that the Company received the notification prepared in accordance with Article 69.1.2 in connection with Article 69.2.2 of the Act of July 29, 2005 on Public Offering, Conditions Governing the Introd…

    Conclusion of the share donation agreement between the Company and the main shareholder and Supervisory Board Member in execution of a non-diluting incentive program in the Company

    The Management Board of Selvita S.A. with its registered office in Krakow (“Company”) hereby informs that on July 8, 2021, shareholder Paweł Przewięźlikowski – being the main shareholder and member of the Supervisory Board of the Company, who holds a total of 4,990,880 shares of the Company, conclud…
    Show more

    Selvita Frequently Asked Questions

    • When was Selvita founded?

      Selvita was founded in 2007.

    • Who are Selvita key executives?

      Selvita's key executives are Miłosz Gruca, Mirosława Zydroń and Dawid Radziszewski.

    • How many employees does Selvita have?

      Selvita has 452 employees.

    • Who are Selvita competitors?

      Competitors of Selvita include Immuneed, Inoviem Scientific and Metrion Biosciences.

    • Where is Selvita headquarters?

      Selvita headquarters is located at Michała Bobrzyńskiego 14, Kraków.

    • Where are Selvita offices?

      Selvita has offices in Kraków, Poznań, Boston, South San Francisco and in 1 other location.

    • How many offices does Selvita have?

      Selvita has 5 offices.